Evidence map›Paper›PMID 26773659›Full record

ArticleBiomaterials2016

Injectable dual-gelling cell-laden composite hydrogels for bone tissue engineering.

T N Vo, S R Shah, S Lu, A M Tatara, E J Lee, T T Roh, Y Tabata, A G Mikos

Abstract read
In one paragraph

Article in Biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Advances in Synthetic Grafts in Spinal Fusion Surgery.International journal of spine surgery · 2023
    Article
  10. Review
  11. Article
  12. Fabrication and characterization of osteogenic function of progenitor cell-laden gelatin microcarriers.Journal of biomedical materials research. Part B, Applied biomaterials · 2022
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

T N VoDepartment of Bioengineering, Rice University, P.O. Box 1892, MS 142, Houston, TX, 77251-1892, USA.
S R ShahDepartment of Bioengineering, Rice University, P.O. Box 1892, MS 142, Houston, TX, 77251-1892, USA.
S LuDepartment of Bioengineering, Rice University, P.O. Box 1892, MS 142, Houston, TX, 77251-1892, USA.
A M TataraDepartment of Bioengineering, Rice University, P.O. Box 1892, MS 142, Houston, TX, 77251-1892, USA.
E J LeeDepartment of Bioengineering, Rice University, P.O. Box 1892, MS 142, Houston, TX, 77251-1892, USA.
T T RohDepartment of Bioengineering, Rice University, P.O. Box 1892, MS 142, Houston, TX, 77251-1892, USA.
Y TabataDepartment of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.
A G MikosDepartment of Bioengineering, Rice University, P.O. Box 1892, MS 142, Houston, TX, 77251-1892, USA; Department of Chemical and Biomolecular Engineering, Rice University, P.O. Box 1892, MS 362, Houston, TX, 77251-1892, USA. Electronic address: mikos@rice.edu.
Rice University · USKyoto University · JP

Funding

In Situ Hardening Cell-Laden Constructs for Osteochondral Tissue EngineeringR01AR068073 · NIAMS · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2015 to 2019
$1.7M
In Situ Hardening Cellular Constructs for Craniofacial Bone RegenerationR01DE017441 · NIDCR · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2008 to 2012
$1.6M
Injectable, In Situ Forming Hydrogels for Craniofacial Tissue EngineeringF31DE023999 · NIDCR · RICE UNIVERSITY · PI VO, TIFFANY N · 2013 to 2015
$94k
NIAMS NIH HHS R01 AR068073NIDCR NIH HHS F31 DE023999NIDCR NIH HHS R01 DE017441
6 · The paper itself

Abstract

The present work investigated the osteogenic potential of injectable, dual thermally and chemically gelable composite hydrogels for mesenchymal stem cell (MSC) delivery in vitro and in vivo. Composite hydrogels comprising copolymer macromers of N-isopropylacrylamide were fabricated through the incorporation of gelatin microparticles (GMPs) as enzymatically digestible porogens and sites for cellular attachment. High and low polymer content hydrogels with and without GMP loading were shown to successfully encapsulate viable MSCs and maintain their survival over 28 days in vitro. GMP incorporation was also shown to modulate alkaline phosphatase production, but enhanced hydrogel mineralization along with higher polymer content even in the absence of cells. Moreover, the regenerative capacity of 2 mm thick hydrogels with GMPs only, MSCs only, or GMPs and MSCs was evaluated in vivo in an 8 mm rat critical size cranial defect for 4 and 12 weeks. GMP incorporation led to enhanced bony bridging and mineralization within the defect at each timepoint, and direct bone-implant contact as determined by microcomputed tomography and histological scoring, respectively. Encapsulation of both GMPs and MSCs enabled hydrogel degradation leading to significant tissue infiltration and osteoid formation. The results suggest that these injectable, dual-gelling cell-laden composite hydrogels can facilitate bone ingrowth and integration, warranting further investigation for bone tissue engineering.

Indexed as

InjectionsAlkaline PhosphataseAnimalsBiological AssayBone and BonesCells, ImmobilizedGelatinHydrogelsMesenchymal Stem CellsMicrospheresRats, Inbred F344Tissue EngineeringX-Ray MicrotomographyAlkaline PhosphataseGelatinHydrogelsCritical size cranial defectGelatin microparticlesMesenchymal stem cellsMineralizationN-isopropylacrylamide

Identifiers

PMID26773659
PMCPMC4754149
OpenAlexW2197284960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.